563
Participants
Start Date
June 16, 2017
Primary Completion Date
March 12, 2018
Study Completion Date
March 12, 2018
ingenol disoxate gel 0.018%
Ingenol disoxate gel is a novel ingenol derivative being developed for field treatment of AKs on treatment areas of up to 250 cm2 (40 in2) on the face, chest and scalp.
ingenol disoxate gel 0.037%
Ingenol disoxate gel is a novel ingenol derivative being developed for field treatment of AKs on treatment areas of up to 250 cm2 (40 in2) on the face, chest and scalp.
Vehicle gel
Vehicle to ingenol disoxate gel with no active ingredient
Investigational Site, Dresden
Investigational Site, Berlin
Skin Search of Rochester, Inc., Rochester
The GW Medical Faculty Associates, Washington D.C.
DermAssociates, PC, Rockville
Investigational Site, Hamburg
Gwinnett Clinical Research Center, Inc., Snellville
Investigational Site, Hanover
MedaPhase, Newnan
Investigational Site, Pamplona
Park Avenue Dermatology, Orange Park
Research Institute of the Southeast, LLC, West Palm Beach
Visions Clincal Research, West Palm Beach
Investigational Site, Chambray-lès-Tours
Investigational Site, Recklinghausen
Investigational Site, Valencia
Laser & Skin Surgery Center of Indiana, Carmel
Research Institute of Deaconess Clinic, Evansville
Investigational Site, Münster
Clarkston Skin Research, Clarkston
Investigational Site, Frankfurt am Main
Burke Pharmaceutical Research, Hot Springs
Center for Clinical Studies, Houston
Suzanne Bruce and Associates, P.A., The Center for Skin Research, Katy
Austin Institute for Clinical Research, Inc., Pflugerville
AboutSkin Dermatology and DermSurgery, PC, Greenwood Village
Colorado Medical Research Center, Inc., Denver
Clinical Studies Group, Henderson
Dermatology Specialists, Inc., Oceanside
Skin Surgery Medical Group, Inc., San Diego
Therapeutics Clinical Research, San Diego
University Clinical Trials, Inc., San Diego
Contour Dermatology & Cosmetic Surgery Center, Rancho Mirage
Dermatology Specialists, Inc, Murrieta
Southern California Dermatology, Inc., Santa Ana
Center for Dermatology Clinical Research, Inc., Fremont
Investigational Site, Schweinfurt
Premier Clinical Research, Spokane
Dermatology and Dermatologic Surgery, Danbury
ActivMed Practices & Research, Inc., Methuen
The Dermatology Group, P.C., Verona
Investigational Site, Surrey
Investigational Site, Vancouver
Investigational Site, Winnipeg
Investigational Site, Fredericton
Investigational Site, Ajax
Investigational Site, Barrie
Investigational Site, London
Investigational Site, Mississauga
Investigational Site, Peterborough
Investigational Site, Waterloo
Investigational Site, Drummondville
Investigational Site, Nice
Investigational Site, Saint-Etienne
Investigational Site, Badalona
Investigational Site, Dundee
Investigational Site, Airdrie
Investigational Site, Middlesbrough
Investigational Site, Redhill
Lead Sponsor
LEO Pharma
INDUSTRY